Top Markets
Coin of the day
PRF Technologies Ltd. PRF Technologies Ltd.

PRF Technologies Ltd.

PRFX
Clasificación en acciones #40770
PRF Technologies Ltd. operates as a specialized pharmaceutical company,... PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Precio por acción
$1.04
Capitalización bursátil
$83.35K
Cambio (1 día)
0.49%
Cambio (1 año)
-85.72%
País
IL
Comercio PRF Technologies Ltd. (PRFX)

Categoría

Ratio P/B de PRF Technologies Ltd. (PRFX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de PRF Technologies Ltd., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de PRF Technologies Ltd. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras